Amide Lab at the Engine Accelerator in Cambridge, MA (courtesy Amide)

MIT spin­out aims to im­prove man­u­fac­tur­ing of pep­tides 

Amide Tech­nolo­gies is now mar­ket­ing its pep­tide man­u­fac­tur­ing tech­nol­o­gy at a time when pep­tide-based ther­a­pies such as No­vo Nordisk’s We­govy and Eli Lil­ly’s Moun­jaro are …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.